Bingyi Yang

875 total citations
32 papers, 575 citations indexed

About

Bingyi Yang is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Genetics. According to data from OpenAlex, Bingyi Yang has authored 32 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Obstetrics and Gynecology, 17 papers in Reproductive Medicine and 9 papers in Genetics. Recurrent topics in Bingyi Yang's work include Endometrial and Cervical Cancer Treatments (20 papers), Endometriosis Research and Treatment (11 papers) and Estrogen and related hormone effects (8 papers). Bingyi Yang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (20 papers), Endometriosis Research and Treatment (11 papers) and Estrogen and related hormone effects (8 papers). Bingyi Yang collaborates with scholars based in China, Germany and Australia. Bingyi Yang's co-authors include Xiaojun Chen, Xuezhen Luo, Chengcheng Ning, Weiwei Shan, Qin Zhu, Bingying Xie, Hongwei Zhang, Qiaoying Lv, Chao Gu and Youji Feng and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Bingyi Yang

27 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bingyi Yang China	15	357	279	102	83	78	32	575
Yoshiaki Norimatsu Japan	16	386 1.1×	249 0.9×	109 1.1×	63 0.8×	21 0.3×	63	634
Norbert Drieschner Germany	12	238 0.7×	219 0.8×	206 2.0×	23 0.3×	83 1.1×	20	608
S.F. Yim Hong Kong	11	136 0.4×	110 0.4×	268 2.6×	42 0.5×	31 0.4×	19	519
R.J. Zaino United States	9	203 0.6×	182 0.7×	133 1.3×	53 0.6×	290 3.7×	14	537
Radosław Charkiewicz Poland	13	91 0.3×	128 0.5×	197 1.9×	106 1.3×	17 0.2×	36	473
Şeyda Karaveli Türkiye	10	71 0.2×	82 0.3×	187 1.8×	50 0.6×	51 0.7×	34	385
Huaiwu Lu China	12	106 0.3×	75 0.3×	221 2.2×	85 1.0×	15 0.2×	54	492
Jeroen Depreeuw Belgium	9	289 0.8×	199 0.7×	129 1.3×	23 0.3×	18 0.2×	13	491
Hidehiro Mori Japan	10	193 0.5×	227 0.8×	62 0.6×	211 2.5×	103 1.3×	22	431
Thomas K. Barton United States	8	119 0.3×	94 0.3×	80 0.8×	42 0.5×	219 2.8×	9	433

Countries citing papers authored by Bingyi Yang

Since Specialization

Citations

This map shows the geographic impact of Bingyi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyi Yang more than expected).

Fields of papers citing papers by Bingyi Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyi Yang. The network helps show where Bingyi Yang may publish in the future.

Co-authorship network of co-authors of Bingyi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingyi Yang. A scholar is included among the top collaborators of Bingyi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingyi Yang. Bingyi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Yali, et al.. (2025). Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment. Journal of Gynecologic Oncology. 36(6). e111–e111.

Wang, Lulu, Bingyi Yang, Shi‐Min Zhao, et al.. (2025). Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling. Science Translational Medicine. 17(818). eadp0064–eadp0064.

Song, Chengcheng, Yingying Qin, Bingyi Yang, et al.. (2024). Deleterious variants in RNF111 impair female fertility and induce premature ovarian insufficiency in humans and mice. Science China Life Sciences. 67(7). 1325–1337. 2 indexed citations

Wang, Qian, et al.. (2024). Clinicopathological characteristics and fertility preserving treatment of atypical polypoid adenomyoma. Frontiers in Oncology. 14. 1386931–1386931.

Yang, Bingyi, Weiwei Shan, Wenyu Shao, et al.. (2023). Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study. Gynecologic Oncology. 174. 133–141. 5 indexed citations

Yang, Bingyi, Weiwei Shan, Wenyu Shao, et al.. (2022). 2022-RA-170-ESGO Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phaseIIstudy. International Journal of Gynecological Cancer. 32. A89–A90. 1 indexed citations

Cheng, Yali, Bingyi Yang, Weiwei Shan, et al.. (2022). NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB. Cancer Gene Therapy. 29(10). 1452–1462. 4 indexed citations

Hu, Jiali, et al.. (2022). Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis. Frontiers in Genetics. 13. 952083–952083. 2 indexed citations

Chen, Xiaojun, Yida Wang, Bingyi Yang, et al.. (2020). Deep learning for the determination of myometrial invasion depth and automatic lesion identification in endometrial cancer MR imaging: a preliminary study in a single institution. European Radiology. 30(9). 4985–4994. 71 indexed citations

10.

Yang, Bingyi, Yuhui Xu, Qin Zhu, et al.. (2019). Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecologic Oncology. 153(1). 55–62. 71 indexed citations

11.

Yang, Bingyi, Hongwei Zhang, Qin Zhu, et al.. (2018). Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients. Journal of Gynecologic Oncology. 29(3). e35–e35. 50 indexed citations

12.

Luo, Xuezhen, et al.. (2018). The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification. Journal of Gynecologic Oncology. 30(1). e13–e13. 47 indexed citations

13.

Lv, Qiaoying, Bingyi Yang, Chengcheng Ning, et al.. (2018). Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer. Biochemical and Biophysical Research Communications. 503(4). 2918–2923. 14 indexed citations

14.

Shan, Weiwei, Qin Zhu, Bingyi Yang, et al.. (2018). Five cases of uterine perivascular epithelioid cell tumors (PEComas) and review of literature. Archives of Gynecology and Obstetrics. 299(1). 185–190. 18 indexed citations

15.

Lv, Qiaoying, Yali Cheng, Weiwei Shan, et al.. (2018). A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen. Cancer Letters. 442. 137–147. 17 indexed citations

16.

Li, Jun, Qin Zhu, Bingyi Yang, et al.. (2018). Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients. European Journal of Obstetrics & Gynecology and Reproductive Biology. 222. 151–154. 19 indexed citations

17.

Xie, Bingying, Bingyi Yang, Chengcheng Ning, et al.. (2017). Risk Factors for Unsuccessful Office-Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage. Journal of Minimally Invasive Gynecology. 25(4). 724–729. 21 indexed citations

18.

Lv, Qiaoying, Bingying Xie, Bingyi Yang, et al.. (2017). Increased TET1 Expression in Inflammatory Microenvironment of Hyperinsulinemia Enhances the Response of Endometrial Cancer to Estrogen by Epigenetic Modulation of GPER. Journal of Cancer. 8(5). 894–902. 24 indexed citations

19.

Ning, Chengcheng, Bingying Xie, Lin Zhang, et al.. (2016). Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen. Cancer Research. 76(6). 1354–1366. 61 indexed citations

20.

Xie, Bingying, Qiaoying Lv, Chengcheng Ning, et al.. (2016). TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation. Biochemical and Biophysical Research Communications. 482(4). 857–862. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact